Bone Health Risks
3 articles on Bone Health Risks, written by Shotlee and medically reviewed for clinical accuracy.
GLP-1 Weight-Loss Drugs Face Bone Health Risks in Older Adults
Emerging research is raising questions about GLP-1 weight-loss drugs like Ozempic and Wegovy, showing a potential link to bone loss and fractures in older adults. A major study in the Journal of Clinical Endocrinology & Metabolism found higher fragility fracture risks among seniors on these medications. Experts stress monitoring and preventive steps to balance benefits with bone protection.
5 min read
GLP-1 Drugs Raise Osteoporosis Risk 30% – Hollywood Stars Beware
A shocking University of Pennsylvania study links popular GLP-1 weight loss drugs to a 30% higher risk of osteoporosis and dramatic rises in other bone-weakening conditions. Hollywood stars chasing rapid fat loss may face painful complications like fractures and tendon ruptures. Experts warn that even small risk increases can be devastating for individuals.
6 min read
GLP-1 Drugs Like Ozempic Raise Bone and Tendon Injury Risks, Study Suggests
New research reveals GLP-1 medications like Ozempic may significantly elevate risks of bone disorders and tendon injuries. Analyzing nearly 150,000 patients, the study found 30% higher osteoporosis rates and 50% increased tendon rupture risks over five years. Experts urge bone density monitoring amid these findings.
5 min read